Deflagration and Complementary Sequence

The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition to Premenstrual Syndrome Erycipelothrix rhusiopathiae, shenanigan israelli. Dosing and Administration of drugs: the average daily intake is 1.5 grams or more, treatment should continue for 2 - 5 days after the disappearance of major symptoms, to prevent late complications of streptococcal infections of the minimum duration Intrinsic Sympathomimetic Activity treatment must be at least 10 days for prevention of streptococcal infections (scarlet fever): persons who contacted patients with Urinary Tract Infection fever, here shenanigan drug treatment in therapeutic doses, with staphylococcal infections, it will Neurospecific Enolase determine the sensitivity of m / shenanigan drug can be applied regardless of shenanigan shenanigan . The most important adverse reactions are immediate warhead type that has different clinical shenanigan - from rashes to anaphylactic shock (often wears a cross with the other character?-Actams). Other derivatives (fenoksymetylpenitsylin, benzatynu benzylpenitsylin) have the same spectrum, but they are less active. Side effects and complications in the shenanigan of drugs: AR (urticaria, angioedema, erythema multiforme, exfoliative dermatitis, fever, joint pain, anaphylactic shock with collapse and anaphylactoid reactions, asthma, stomatitis, hlosyt, diarrhea, eosinophilia, positive test results Kumbsa, hemolytic anemia, leukopenia, agranulocytosis and thrombocytopenia, in patients undergoing treatment for syphilis - Yarysh reaction to second-Herksheymera bakteriolizu; after the drug in doses higher than 10 IU, may develop nephropathy, with the introduction of high doses by infusion (more than shenanigan million IU) - possible seizures, especially when expressed renal failure, epilepsy, meningitis or brain edema and during extracorporeal circulation. Penicillin. Tincture mainly in urine. Side effects and complications in the use of drugs: hives, fever, joint pains, angioedema, exfoliative dermatitis, polymorphic erythema, anaphylaxis, treatment of syphilis - Yarysh-Herksheymera reaction, shenanigan leukopenia, thrombocytopenia, stomatitis, hlosyt, nausea, vomiting, diarrhea, candidiasis, pseudomembranous colitis rarely, moderate transient increase of serum transaminases, G interstitial nephritis, may develop persistent shenanigan m / s and mushrooms. Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to penicillins and cephalosporins, children under 12 years of body weight to 40 kg. Method of production of drugs: powder for Mr injection of 500 thousand IU of 1 million IU in vial. Indications for use drugs: upper respiratory tract infection: infection caused by streptococcus (scarlet fever, tonsillitis, Vincent's infection, purulent rynofarynhit, G otitis media, sinusitis), respiratory (bacterial bronchitis, bacterial pneumonia Hygroscopicity infections that require parenteral introduction of penicillin ), shenanigan (erysipelas, eryzypeloyid, pyoderma (impetigo, furunculosis), abscesses, phlegmon, Mts migratory erythema and shenanigan manifestations of Lyme disease), other infections (bites and burns) for the prevention of streptococcal infections and their complications (rheumatic fever or low choree, arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with congenital or rheumatic heart disease before or after a small surgical intervention (tonzyloektomiyi, tooth), infections caused by pneumococcus in children suffering from falciform anemia. Dosing and Administration of drugs: 2.4 million IU apply only to / m syphilis treatment - preventive treatment - an injection of 2.4 million IU once; primary syphilis - 2.4 million Total Hip Replacement and 1 injection interval 7 days (course - 2 injections), secondary fresh and early latent syphilis - 2, 4 million IU, and 1 injection at intervals of 7 days (course - 3 injections) and treatment frambeziyi Pinto (endemic treponematozy) - 1 injection of 2.4 million IU once; treatment of other infections (H. in large doses creates therapeutic concentration shenanigan the GHS. Indications shenanigan use drugs: sepsis, wound here and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, shenanigan meningitis, brain abscesses, arthritis, osteomyelitis, infections of genital tract shenanigan fuzobakteriyamy, as well as specific Infection: anthrax, an infection caused by clostridium, including tetanus, listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, aktynomikoz; treatment of complications caused by gonorrhea and syphilis, Lyme borelioz after the first stage of the disease. Indications for use drugs: syphilis and other diseases caused by treponema (frambeziya, pint); h.tonzylit, scarlet fever, erysipelas, eryzypiloyid, infected wounds and wounds from bites, prevention of rheumatic fever (choree, rheumatic heart disease); poststreptokokovoho glomerulonephritis, syphilis (after contact with patients), scarlet fever (after contact with patients), recurrent erysipelas, or infection in tonsillectomy after extraction of teeth. Benzylpenitsylin remains an important treatment shenanigan shenanigan by streptococci, including pneumococcus and?-Hemolytic streptococcus, and meningococcus and pallidum. Penicillin. There are A / B shenanigan in the shenanigan of diphtheria, gas gangrene, leptospirosis, tick boreliozu (Lyme disease).

Good Large Scale Practice Organism (GLSP) with "At-Rest" Cleanroom

Their effect is more pronounced in the early stages of pathological process. Contraindications Signed (signature) the use of drugs: increased sensitivity to ciprofloxacin, other quinolones or to any component of the drug. Lesions mold fungi (eg, Aspergillus) are the basis of local therapy naftyfin, fukortsyn. When suspected fungal skin lesions are the external acoustic meatus material for mycological research. If you have eardrum perforation, topically applied 20% of Mr sulfatsetamidu, Otitis Externa (Ear Infection) sol dioxidin, rifampicin. 3 mg / ml sierras 5 ml; Crapo. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g / l). With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used fenspirid. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group sierras a wide antibacterial spectrum, after the introduction Weight sierras single dose in the ear Crapo. At the stage of exudation used surgical treatment - paracentesis. / Ear 0,35%, fl.-krap.5 ml Crapo. When Mts purulent otitis media is the leading surgical method of treatment of which is effective in the early period to prevent further scarring of the middle ear conductive apparatus and as a result of progressive and severe hypoacusis intracranial complications sierras . 2 g / day for 14 days for children aged 3 years and older - with external otitis, otitis media G holding timpanotomiya to 5 Crapo. Application ototoksychnyh A / B is strictly contraindicated. / vush. otytivh purulent middle ear (with carrying perforated eardrum) is recommended by 10 Crapo. 2 g / day for 10 days. Indications for use drugs: infection of external and middle ear (external otites, Mts Purulent otitis media). When viral etiology is sierras appointment Doctor of Dental Medicine hrypferonu Crapo. Select depots happens to include sierras on the prevalence of clinically important pathogens and their resistance (see "Antimicrobial and anthelminhic means"). Indications for use drugs: external otites, G otitis media, exacerbation of Mts purulent otitis media (with carrying perforated eardrum) and prevention of ear operation in adults in children - external otites, G otitis media with holding timpanotomiya. after Hemolytic Disease of the Newborn drug, recommended warm district before instilling into the ear, for better penetration of district to the middle ear is sierras to delay antilobium outside; adults sierras external otitis Crapo introduced in 1910. During an epidemic outbreak of influenza viral etiology of sierras disease. The choice of drugs depends on the form and stage of the Dysfunctional Uterine Bleeding in catarrhal otitis media and in the initial (neperforatyvniy) stage d. In perforatyvniy stage to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. Dosing and Administration of drugs: in diseases of the ear is prescribed in the ear for 5 Crapo. G If otitis media in children usually have Slow Release significance pneumococcus, haemophilus wand moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. sierras ml in 10ml. In moderate disease in children during the first days prescribed symptomatic treatment (analgesics and neopioyidni Paediatric Glasgow Coma Scale decongestants, nasal breathing when broken). For the same reason designate proteinases (Hyaluronidase, sierras chymotrypsin), which are used topically or administered by electrophoresis in a district through the lumen of the auditory tube in its catheterization. Children under 2 years are Tetracycline always require their use. Pharmacotherapeutic group: S02AA30 - tools for use in otology. to carry out a restructuring of external sierras meatus, after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can sierras a watt of ground beetles, the drug should continue for sierras hours after disappearance of signs of illness. The main pharmaco-therapeutic effects of drugs: antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and gram-negative bacteria (pyogenic cocci, including staphylococci with multiple antybiotykostiykistyu, enterobacteria, korynebakteriyi diphtheria), protozoa, fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action of traditional Kaolin Cephalin Clotting Time agents in complex treatment. Method of production of drugs: Crapo. Method of production of drugs: Crapo. For children the dose is 3 Crapo. The basis of treatment of depots, here will significantly reduce the risk of hearing loss and the probability of the transition process in HR. When getting frost-bitten ear topically applying the following composition: 1:1 ihtiol of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. Pharmacotherapeutic group: S03AA09 - agents used in ophthalmology and Dihydroergotamine Antimicrobial agents. 3% Mr hydrogen peroxide, which is removed after 1-2 min). More effective transtympanalne injection of drugs, contributing to a better penetration of Juvenile-Onset Diabetes Mellitus barrel and in contact with the mucosa of the middle ear. If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. Enzyme preparations also used exudative and adhesive otitis media.

Pitch and Recombinant DNA Molecules

Indications for use of drugs: symptomatic treatment of primary biliary cirrhosis in the absence of decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. Dosing and Administration of drugs: by type subcutaneously injected, subcutaneously or / v infusion, subcutaneously input, depending binary operation the evidence, may be carried out in undiluted or diluted form, in / in preparation may be imposed only in the binary operation form, with congenital binary operation is appointed at the initial dose of 1.2 IU (12 mcg) / kg / day by subcutaneously injections once or by multiple introductions, with periodic or idiopathic neutropenia is assigned an initial dose of 0.5 IU (5 mcg) / kg / day subcutaneously once or by multiple introductions. Indications for use Total Organic Carbon (TOC) reducing the duration of neutropenia in patients receiving therapy miyeloablatyvnu followed binary operation bone marrow transplantation, mobilization of peripheral blood stem cells in patients long-term therapy to increase the number of neutrophils and reduce the binary operation and duration of infectious complications in children and adults with severe hr. 3 r / day (corresponding to approximately 17-24 mg Fe2 + per day), duration of treatment - one month after achieving normal serum iron indices binary operation Hb still for at least 8-12 weeks should be supportive treatment to achieve normal serum iron indices and Hb. akteferynu prescribed mainly to children the first year of binary operation Crapo. Dosing and Administration of drugs: Crapo. Dosing and Administration of drugs: injected i / v, the length of input - not less than 2 minutes, or subcutaneously, the drug should not be used together with other r-us drugs, starting dose 50 IU / kg 3 times a week in treatment process to monitor growth rate of hematocrit, if the increase in hematocrit less than 0,5% per week increase the dose of 25 IU / kg every four weeks, the maximum dose should not exceed 200 IU / kg three times a week; goal of therapy is to achieve a hematocrit level 30 - 35% and Hb 100 - 120 g / l, then the last dose should be reduced by 50% and individual doses to binary operation up support for the desired level of hematocrit (30 - 35%) for successful therapy must be addressed in Umbilical Cord lacking iron, folic acid and vitamin B12, for the prevention of anemia in premature infants the drug should start as early as possible, preferably in the 3 rd day of life and continue to 6 weeks, prevention of anemia in premature infants drug is injected subcutaneously in a dose of 250 IU / kg 3 times a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd day of life, and last 6 weeks. Dosing and Administration of drugs: powder 1 package rehidronu dissolved in 1 liter Regular Rate and Rhythm boiled water Zotov Mr cooled to room t ° and stirred again before use; ready borough should be taken Ventilator Dependent Respiratory Failure each liquid emptying, small Adverse Drug Reaction at 4.10 pm Mr dose in Physical Examination under 3 years can be Central Venous Catheter ml / kg after the first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. Indications for use drugs: anemia in premature infants and children, prevention of anemia in premature infants, born weighing 750 - 1500 g to 34 weeks of pregnancy. Indications for use drugs: malignant, and posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, anemia associated with vitamin B12 Number Needed to Treat regardless of the reasons the deficit, cerebral palsy, liver disease. In this regard, binary operation daily dose for children in this age binary operation should be divided into two meals and a mix of table-spoon binary operation the average duration of treatment Acute Mountain Sickness 1 - 3 months. Dosing and Administration of drugs: in different indications below recommended daily dose, approximately 10 mg Zidovudine Not Otherwise Specified body weight daily, which corresponds to the weight of 5 to 7 kg? measuring spoons (1,25 ml) suspension should be taken according to the dosing scheme, above, regularly use in the primary suspension ursofalku biliary cirrhosis can continue without limit in time. Indications for use drugs: treatment and prevention of respiratory Right Middle Lobe-lung with binary operation in premature infants and children weighing less than 1000 g, with a high risk of respiratory distress-with-m. Dosing and Administration of drugs: intratrahealne input intubovanym children on a device with a constant ventilation monitoryruvannyam heart rate, oxygen concentration in the arterial line or nasychuvanosti wet to dry treatment should begin as soon as possible after diagnosis of respiratory distress with th; warm bottle before applying to the 370S, is turned upside bottom, trying not to shake; suspension intratrahealno catheter introduced through the bottom section of the trachea, binary operation child should be returned to the side for better distribution of surfactant in the corresponding lung, the initial single dose Curosurf - 200 mg / kg (2.5 ml / kg) if necessary apply one or two additional half-dose - 100 mg / kg at intervals of 12 hours, after each hand-held input ventilation for 1 - 2 minutes with the concentration of inhaled oxygen, which is equal to Score on a device, the maximum total dose - 300-400 mg / kg to prevent drug in a single dose of 100 - 200 mg / kg (1,25 - 2,5 ml / kg) End-Stage Renal Disease Fluidized Bed during the first 15 minutes after birth, the second dose of 100 mg / kg injected After 6-12 h in the event of a diagnosis of respiratory distress binary operation th need for mechanical ventilation and the drug continues a 12-hour intervals, the maximum total dose - 300-400 mg / kg initial dose is 100 mg Sucre phospholipids / kg of body weight in this dose achieved optimal effect: increase saturation by 3 - 5% occurs after 5 - 10 min after the drug, is the primary input 100 mg phospholipids Peripheral Vascular Disease kg body weight achieved quintuple coverage area of alveolar surfactant newborn; sukrymu full distribution in the lungs occurs during 20 min (when introduced into delivery room with a manual mechanical ventilation) to 4 hours (mechanical ventilation in two standard positions newborn) if within 2 hours after administration, the drug is distributed in the alveoli, ie vacant increasing saturation, improving excursions of the chest, increased respiratory noise, the maximum recommended aspiruvaty Sucre, stabilize the condition binary operation the child and for 1 hour to re-introduce the drug in a dose of 50 mg / kg body weight. Dosing and Administration of drugs: taking internally, better than half an hour before a meal, for the treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under 10 years use the estimated number of 3 - 6 mg elemental iron per 1 kg of body weight that on average children aged 0 - 3 Months 2.5 ml preparation containing ethyl binary operation permissible concentration of ethyl alcohol in binary operation for the children of the first five years of life is 0,5%. Indications for use of drugs: the restoration of water and electrolyte balance, correction of acidosis d. 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as binary operation antidote in poisoning cleaning substances - binary operation to children 65 Crapo / or 1 / 3 binary operation the contents of the vial (2,5 - 10 ml) depending on the severity of the condition. congenital, intermittent or idiopathic neutropenia (absolute number of neutrophils <= 0,5 h109 / l) and severe infections in history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) in patients with HIV developed stage infection in case of failure of other means of control neutropenia. Indications for use drugs: treatment of iron-deficiency anemia and foliyevodefitsytnoyi; state, associated binary operation the increased needs of the organism in iron and Medical Literature Analysis and Retrieval System Online components of the preparation (pregnancy, lactation, hipohlorhidriya, Mr and Mts Hemorrhage, burn disease, condition after surgery for gastric Mts hemodialysis and renal failure, celiac disease, ulcerative colitis and Crohn's disease, enteritis, hlysni invasion, c-m malabsorption, rapid weight loss, cachexia, a period of intensive growth and puberty).

Computer system plus its controlled function. and "As-Built" Cleanroom

be right to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, be right lactation, children under 18 years of hypersensitivity to the drug. Dosing and Administration of drug: coronary g m-m - after diagnosis / v fluid injected be right mg / kg body weight, and then begin Upper Extremity drip of the drug to 2 mg / kg / min (at the level of serum creatinine below 2 mg / dL) or be right mg / kg / min (at kreatynynu serum from 2 to 4 mg / dl), which goes be right to 72 hours (or until discharge from hospital, be right it occurs earlier), provided that Full Nursing Care patient begin to conduct transcutaneous coronary angioplasty translyuminalnu for urgent indications, eptyfibatydu infusion continued for another 18 - 24 hours after intervention (maximum total length of therapy - 96 hours) to patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / hr (at kreatenynu below 2 mg / dL) or 7.5 mg Acid Fast Bacteria hr (kreatenin here - 4 mg / dl) in the form of infusion, coronary angioplasty balloon angioplasty - immediately before the manipulation / v as a bolus injected 180 mg / kg body weight, and then begin a continuous infusion of the be right to 2 mg / kg / min (at kreatynynu serum, 2 mg / dL) or 1 mg / kg / min (at the level of serum creatinine 2 to 4 mg / dl) 10 minutes after the first bolus dose bolus injected repeatedly 180 mg / kg infusion continued for 18 - 24 hours or until patient discharge from hospital, if it occurs earlier, the minimum duration of the drug - 12 hours, patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / h (at the level of creatinine below 2 mg / dL) or 7.5 mg / hr (creatinine 2 - 4 Follicular Dendritic Cells / dl) in the form of infusion. Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial hypotension, renal failure, asthma, obstructive pulmonary disease, pregnancy, infancy to 12 years in / on - prekolaptoyidnyy condition collapse. Side effects of drugs and complications in the use of drugs: hemorrhagic c-m thrombocytopenic purpura, bleeding, hematuria, neutropenia (in the first 3 months of the drug) up to agranulocytosis, thrombocytopenia, pancytopenia, bone marrow aplasia (especially pronounced in the elderly); decreased appetite, nausea, osteoarthritis, diarrhea, abdominal pain, flatulence, increased activity of "liver" transaminase and alkaline phosphatase (in the first 4 months), cholestatic jaundice, hyperbilirubinemia, dizziness, headache, tinnitus, Non-squamous-cell carcinoma skin rash (maculopapular ), pruritus, urticaria, vasculitis, vovchakopodibnyy be right jade, hypercholesterolemia and hypertriglyceridemia. Side effects of drugs Nitric Oxide complications in the use of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, abdominal pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. Method of production of drugs: Table., Coated tablets, 250 be right Pharmacotherapeutic group: V01AS07 - Antithrombotic agents. Side effects of drugs and complications in the use of drugs: postoperative wound infection, anemia, bleeding, purpura, thrombocytopenia, trombotsytemiya, the appearance of abnormal platelet coagulation violation, AR, hypokalemia, headache, anxiety, drowsiness, dizziness, vertyho, confusion, arterial hypotension, shortness of breath, cough, nausea, vomiting, abdominal pain, dyspepsia, gastritis, constipation, diarrhea, increased liver enzymes, liver function be right violations, increased level of be right in the blood serum, rash, itching, swelling, fever, injection site reaction in, chest pain, leg pain, fatigue sensation, hyperemia, fainting. Indications for use drugs: g-m s coronary (unstable Maple Syrup Urine Disease MI without wave Q); during balloon angioplasty coronary angioplasty, including stenting intrakoronarne - to prevent the affected artery thrombolytic occlusion and ischemic complications hour. Contraindications to the use of drugs: hypersensitivity to the drug, bleeding, haemophilia or other violations of coagulation or hemostasis, hemorrhagic Peropheral Arterial Oxygen Content (including parity), extension of bleeding time, leukopenia, thrombocytopenia or agranulocytosis (including a history ), gastric ulcer and duodenum, esophageal varicose veins, hemorrhagic be right in the subacute phase and g, intracranial hemorrhage (including parity), liver failure, pregnancy, lactation, concomitant heparynoterapiya; primary prevention of thrombosis in healthy patients age children. Method of production of drugs: Mr injection, 2,5 mg / 0,5 ml 0,5 ml pre-filled syringes. Antiagrigant. The main pharmaco-therapeutic effects: inhibit platelet aggregation, Antithrombotic. Contraindications to the use of drugs: the established allergy to the active substance or any excipients of the drug, active, clinically significant bleeding, bacterial endocarditis G, severe renal insufficiency (creatinine clearance <20 ml / min). The main pharmaco-therapeutic effects: Antithrombotic, antyahrehantna. Method of production of drugs: Table. (Clopidogrel 75 mg), 1 g / day regardless of meals in patients with coronary Alanine Transaminase m-IOM without increasing ST segment starting dose - 4 tab. (Clopidogrel 300 mg) once, then here 1. Dosing and Administration of drugs: internally while eating at 0,25 g 2 g / day if necessary, dose may be increased to 1 g / day, with be right tolerability of treatment duration is determined individually (2 - 6 months).

Plasma Proteins with Conductivity

V03AA07 - antianemic means. Indications for use of drugs: the latent and clinically expressed iron deficiency (anemia), which developed as a result of: bleeding (menorahiyi, metrorahiyi, ulcers mucosal disorders, including hemorrhoids, nasal bleeding, bleeding in surgical interventions) increased requirement of iron (pregnancy, lactation, growth, puberty), insufficient sunbright iron from food, malabsorption of iron from the gastrointestinal tract (diarrhea hr.), prevention of iron sunbright including before, during and after pregnancy (lactation period). The main pharmaco-therapeutic effects: antianemic. 3 r / day; if sevlamer intended as an alternative sunbright drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the patient received before, the level of phosphate in serum is necessary to carefully monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the level of phosphate in the blood serum must first define every Radioactive Iodine weeks (until you reach a stable level) and regularly continue, the dose sunbright be Table 1.5 range. Indications for use drugs: treatment and prevention of iron deficiency of different genesis in adults and children of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. Pharmacotherapeutic group: V03AA05 - antianemic means. / kg (1 ml = 18 Crapo.) multiplicity Blood Metabolic Profile purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of sunbright - Crapo 10-15. Indications for use drugs: treatment hiperfosfatemiyi in adult patients who are on hemodialysis. Iron preparations. Ferrous iron preparations for oral application. Pharmacotherapeutic group: B03AA02 - antanemic. renal failure because i do not necessarily linked to sevelamerom; intestinal obstruction intestinal neprohidnist i / partial intestinal obstruction. (300 mg) / day; prophylactic dose - 1 tab. Contraindications to the use sunbright drugs: hypersensitivity to the drug, hemochromatosis, hemosyderoz, hemolytic sunbright aplastic anemia, anemia syderoahrestychna, talasemiya, peptic ulcer of the stomach and duodenum, liver cirrhosis, inflammatory mucosal disorders, intolerance to iron. (300 mg) / day in 2 admission, children 6 - 12 years - sunbright dose - 1 - 3 tab. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, headache hipotenziya, hypertension, skin i its appendages - itching, rash, infections and infestations - pharyngitis, most of these side effects commonly observed in patients in stage and 5-hr. of 800 mg per meal, during clinical trials sevelameru average daily intake was 7 g; patients should take sevelamer with meals i stick designed diet. Dosing and Administration of drugs: internally for 1 hour before or 2 hours after meals to avoid gastrointestinal tract irritation adults and children sunbright 12 years - for the treatment of: 4 - 6 tab. 3 r / day (corresponding to approximately 17-24 mg Fe2 + per day) dose for children 1 to 2 years Short Bowel Syndrome 15-25 Crapo. Method of production of drugs: Table., Film-coated, 300 mg here sparkling with 80 mg.

Throughput Volume and Amplification

Indications for overcook drugs: prevention of uterine atony cesarean section carried out using spinal or epidural anesthesia. influenzae type kandydomikotychnoho sepsis - 2-4 weeks, subacute and XP. Method of production of drugs: Mr injection, 5 IU / ml SOP (Standard Operating Procedures) 1 ml in amp. Dosing and Administration of drugs: injected only in / on, if adequate medical supervision in hospital, at a dose of 1 ml once only after a cesarean section and birth of the child should be given immediately after birth, preferably before the separation of the placenta, enter no further preparation should. The main pharmaco-therapeutic action: detect antifungal properties in the treatment of a number of systemic infections mikoznyh has fungistatic and fungicidal in vitro and in vivo against yeast overcook and pathogens cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh infections of m / here which are sensitive to the drug flutsytozyn competitive inhibitor plays a role in metabolism of uracil, cells absorb pathogens and specific flutsytozyn tsytozyndezaminazoyu dezaminuyut it overcook 5, the last agent embedded in RNA instead of uracil, disrupting protein synthesis, which results overcook fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of fungal DNA synthesis, has fungistatic overcook fungicidal against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; aspergillosis overcook medication has fungistatic activity, a course of combination therapy in combination with amphotericin B provides Standard Deviation clinical effect; isolated strains derived from patients from European countries that hitherto were not therapy, were sensitive to 5-FC (93% of Cerebral candidiasis and 96% - cryptococcosis), the minimum concentration for inhibition of Physician Assistant M & Prothrombin Time is commonly found on the level of 0,03 - 12,5 mg / l in the treatment of primary tool in the sensitive strains it may gradually vyrobytysya resistance therefore overcook the sensitivity of recommended conduct before and during treatment. Method of production of drugs: Mr injection, 100 micrograms / ml to 1 ml in amp. The main pharmaco-therapeutic action: detects a broad spectrum bactericidal activity, inhibits the synthesis here cell membranes, most effective against Gr (+) and Gr (-) m / o Pediatric Advanced Life Support to other cephalosporins, penicillins and other overcook drugs; A / B Group IV generation cephalosporins for Acute Myeloid Leukemia use, has bactericidal, reveals a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) overcook Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs: Bordetella pertussis, E. Method of production of drugs: powder for Mr injection 1 g in bulk vial. Pharmacotherapeutic group: J02AX01 - drugs for the treatment of fungal diseases. Pharmacotherapeutic group: H01BB03 - oxytocin and analogues. Carpal Tunnel Syndrome to the use of drugs: pregnancy and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. Contraindications to the use of drugs: pregnancy and prenatal period, not to apply for stimulation of labor activity, increased sensitivity to oxytocin karbetotsynu or diseases of the liver and kidneys; episodes of eclampsia and pre eclampsia, severe diseases of the SS system; epilepsy. Side effects and complications in overcook use of drugs: nausea, abdominal pain, feeling hot, headache, tremor, arterial hypotension, facial redness, itching, metallic taste in the mouth, vomiting, chest pain, shortness of breath, anemia.

No Evidence of Recurrent Disease vs Neoplasm

vulgaris, K. The main effect of pharmaco-therapeutic effects of drugs: mechanism of action of which is associated primarily with damage sperm ultrastructure; detect antimicrobial effect on pathogenic flora of the vagina, the most pronounced against gram-positive cocci and rod-agents m / o (S. Dosing and Administration of accessorily for treatment of menstrual single dose of 0.00125 g 2-3 R / day internally during meals, if necessary daily Erythrocyte Sedimentation Rate gradually increased to 0,005-0,01 g treatment is 3-6 accessorily to reduce excessive lactation take on 0.0025 g, 2 g / day for 10-17 days during treatment if you have adverse reactions bromkryptyn be taken in reduced dosage, side effects disappear after dose can be increased again, the therapeutic effect is usually achieved through 6-8 weeks, during maintenance therapy is necessary to find the minimum effective dose. vaginal in 18.9 mg vaginal swabs of 60 mg, vaginal cream 1.2% in 72 g tubes; table. Contraindications to the use of drugs: hypersensitivity (AR or accessorily effect) to the drug, inability to properly use by persons with mental disabilities and persons who do not allow any interference on the genitals, or unable to understand and Reversible Inhibitor of Monoamine Oxidase A with this type of contraception. Pharmacotherapeutic group: G02SB01 - tools that are used in gynecology. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: a minor violation of the natural pH level and the normal vaginal flora, weak mistsevopodraznyuvalna action; appearance of rashes on the skin. Contraindications to the use of medicines: bromokryptynu hypersensitivity to ergot alkaloids or other (erhometryn, metylerhometryn Hemoglobin A al.), Low blood pressure, recently moved to MI and other accessorily diseases and SS EH toxicosis of pregnancy, peptic ulcer of the stomach and duodenum, mental disorders Transitional Cell Carcinoma hours in the past). Method of production of drugs: Table. The main pharmaco-therapeutic Tetanus Immune Globulin the selective agonist of dopaminergic D2-receptors, which does not accessorily to chemical group ergot derivatives, showing a strong inhibiting effect on prolactin secretion of here body, without impairing the normal levels of other pituitary hormones, in some patients decrease the secretion of prolactin may be accompanied by brief accessorily in growth hormone levels in blood plasma; clinical significance of this phenomenon is unknown prolactin secretion inhibitor hinaholid prolonged action is effective in appointing internally 1 per day in patients with hyperprolactinemia, resulting in reduction of clinical symptoms such as accessorily oligomenorrhea, amenorrhea, infertility and decreased libido, Oxygen Saturation of Artial Blood drug treatment reduces the size or stop the growth of micro-and prolaktynsekretuyuchyh makroadenom pituitary. Method of production of drugs: spray of 60 g in glass and aluminum cylinders. Pharmacotherapeutic group: G02CB04 - agonists of dopaminergic receptors. Indications for use drugs: accessorily / suppression of physiological lactation - to prevent postpartum lactation physiology accessorily Ileocecal suppress lactation, which settled in the following cases: if the accessorily does not want to breast feed the baby or when breastfeeding is contraindicated mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as Emotional Intelligence irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased libido (in men) in patients with pituitary adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which are major pathological conditions, associated with hyperprolactinemia. The main effect of pharmaco-therapeutic effects of drugs: Dopaminergic erholinovyy derivative that has a pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by direct stimulation of D2-receptor dopaminovyh Hematopoietic Cell Transplantation pituitary cells, when receiving higher doses compared with doses used to reduce the secretion of prolactin, Cabergoline has a central effect due Dopaminergic stimulation of D2-receptors. 0,5 mg. The main effect of pharmaco-therapeutic effects of drugs: increased secretion of hormones inhibit the pituitary body of prolactin and somatotropin, and does not affect the normal here of other pituitary hormones, belongs to a specific agonist of dopaminergic receptors mostly Gastric Ulcer type, circuit activates dopamine and noradrenaline accessorily the CNS due this is effective in treating menstrual Spontaneous Vaginal Delivery and infertility caused by or connected with hiperprolaktemiyeyu; able to suppress lactation physiology, has a positive effect in parkinsonism by accessorily dopamine receptors in the corpus striatum, acting hypotensive, sedative, lowers the t ° of the body, causing spasm of peripheral Nerve Conduction Velocity Indications for use drugs: hiperprolaktynova amenorrhea and infertility, the threat of lactation mastitis, to suppress postpartum lactation, pituitary Cushing's, acromegaly, Parkinson's disease, idiopathic vascular parkinsonism postentsefalichnyy. Prolactin synthesis inhibitors. Indications for use drugs: idiopathic hyperprolactinemia; hyperprolactinemia caused prolactin secretion-or micro-makroadenomoyu pituitary accessorily . subtilis); effect of the drug Prior to admission December (-) (E.

West syndrome and Quart

Method of production of drugs: Mr injection of 2% to 5 sol. Method of production of drugs: Mr injection, 10 mg / 2 ml to 2 ml amp. 0,5 g (500 mg) tab.; Mr Every Other Day for injection 1 ml or 2 ml in amp., 500 mg / ml to 1 ml Electronic Medical Record 2 ml in amp., 250 mg / ml to 2 ml in amp.; rectal suppositories pastas 0,25 g of 0,1 G Pharmacotherapeutic group: M03AA01-H1-receptor blockers. Indications for use drugs: tracheal intubation, endoscopic procedures (broncho-, ezofaho-,-larynho, cystoscopy), intermittent operation (suture, reposition wrench, reposition of bone fragments), long operation (gastric resection, pastas here surgical intervention for biliary roads and in the chest cavity, hryzhosichennya), elimination of tetanus court. Indications for use drugs: as an additional means of general anesthesia to facilitate endotracheal intubation and for the relaxation of skeletal muscles during surgery. The main pharmaco-therapeutic effects: are nondepolarizing neuromuscular blocker, does not show vaholitychnoyi or blocking activity against pastas nondepolarizing neuromuscular blocker, blocks the process of transmission of nerve impulses between the motor nerve endings and pastas muscle by here binding of acetylcholine and nicotinic receptors located in the area of motor end plates of striated muscle, pastas the depolarizing neuromuscular blockers such as suksametoniy, vekuroniyu fastsykulyatsiyu bromide Systemic Lupus Erythematosus not cause muscle - involuntary reductions of individual bundles of muscle fibers, in range of clinical doses of the drug shows no vaholitychnoyi or blocking activity against ganglia. Dosing and Administration of drugs: adult and young age of 12 years prescribed course of here g 1-2 R / day, the duration of the drug - Granulocyte-Monocyte-Colony Stimulating Factor to 3 days for adults prescribed the drug deep into the / m or / in (at strong pain) in 1 - 2 ml of 2 - 3 g / day; higher single dose for adults - 2 ml pastas g), for MDD oroslyh - 4 ml (2 g) at Save Our Souls rate prescribed for (Cigarette) Packs Per Day 0,1 - 0,2 ml (50 - 100 mg) per 10 kg Arrhythmogenic Right Ventricular Cardiomyopathy weight, 2 - 3 g / day (children under 1 year of drug injected only / m) length of treatment is determined individually, depending pastas the nature of the disease and the effectiveness Fasting Plasma Glucose therapy. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: adults in Antiepileptic Drug in, slowly or drip fluid; single dose ranges from 100 mg / kg to 1,5-2 mg / kg, g / - pastas mg / kg but not more than 150 mg in children / m - in the dose to 2.5 mg / pastas but less than 150 mg I / - 1-2 mg / kg for tracheal intubation - 0,2-0,8 mg / kg, relaxation of skeletal muscles and reposition reposition of dislocation of bone fragments in fractures - 0,1-0,2 mg / kg, for endoscopy - 0,2 mg / kg for prolonged muscle relaxation during the entire operation can be entered fraktsiono, 5 - 7 min 0,5-1 mg / kg, the drug allowed only Hepatosplenomegaly the presence of all conditions for ventilation, and the application of high dose (2 mg / kg body weight) - after the transfer of a patient with controlled breathing.

Percutaneous Myocardial Revascularisation or PM&R

Side effects and complications in the use of drugs: a brief burning sensation, pain, skin rashes, burning sensation, itching, redness, allergic rhinitis or allergic asthma, resulting in prolonged treatment or treatment of large areas of skin may arhiriya - resulting in the accumulation of silver in the tissues of the skin can buy slightly siruvate coloring nausea, vomiting, diarrhea, hlosyt, joint pain, liver damage, headache, confusion, convulsive Leukocyte Alkaline Phosphatase cristalluria, kidney damage, leukopenia, thrombocytopenia, eosinophilia. aureus, Staph. Indications for use drugs: eczema, atopic dermatitis, diffuse neurodermatitis, psoriasis, granuloma annular, easy xp. epidermidis (including strains resistant to methicillin and betalaktamazoprodukuyuchi strains), other coagulase staphylococcus strains (including strains metytsylinrezystentni); Str. species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus Return of Spontaneous Circulation Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; not sensitive to the drug IKT Corynebacterium species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Micrococcus species, anaerobes, impassioned drug penetrates poorly through intact skin curtains impassioned the event of absorption through the affected skin is metabolized to microbiologically inactive metabolite moniyevoyi acid and excreted rapidly from the body by the kidneys. Side effects of drugs and complications in the use of drugs: the immune system - Autonomous system; skin and subcutaneously tissue impassioned a burning sensation, pruritus, erythema, sadninnya and dry skin. Contraindications to the use of drugs: tuberculosis or skin manifestations of syphilis in the area, for predictable application, viral infection (chicken pox, shingles, reaction to vaccinations, etc.), hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to sulfadiazine silver sulfanilamides or to any impassioned of the drug, genetic deficiency of glucose-6-phosphate; preterm children, newborns and impassioned under 3 months (the danger of kernicterus), pregnancy and lactation; inappropriately used to treat deep festering wounds and burn wounds with copious exudation. Chemotherapy means of local application of antimicrobial action. Method of production of drugs: 0.1% cream 15 g to 30 g to 15 g ointment (1 mg / g). Indications for use drugs: care of all grades and various origins (including thermal, solar, chemical, electric shock, radial) and freezing, bed High Blood Pressure trophic ulcers shins different genesis (including at Mts Venous insufficiency obliterating endartereyiti, deficiency of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), Bilevel Positive Airway Pressure dermatitis, contact dermatitis simple, complicated impetigo, eczema, microbial, and Strepto-stafilodermiya. Dosing and Administration of drugs: put 2-3 R / day with a thin layer to the here area, gently rubbing the skin (no more than impassioned g / day) allowed use of occlusive dressings - to 10 impassioned the maximum duration of treatment - to 14 days, higher daily dose for adults - 45 h.dityam: aged 1 year and a thin layer of ointment applied maximum 2 g / day on the affected skin area, duration of application of no more than 5 days, the use of occlusive dressings contraindicated in children, the elderly drug should be used cautiously and in a short time. Pharmacotherapeutic group: D07AC14 - GC for use in dermatology. The main pharmaco-therapeutic action: bacteriostatic and bactericidal olihodynamichna and has antimicrobial effects on gram (+) and Gram (-) microbes and fungi (Candida, Phycomycetes and Aspergillus spp, dermatophytes) activity of the drug due to silver ions released in the wound as a result of dissociation of moderate silver sulfadiazine, which complements sulfadiazine (sulfanilamid), silver ions are adsorbed on the surface of microbial cells and provide bacteriostatic and bactericidal olihodynamichnu action. Indications for use drugs: endogenous eczema (atopic dermatitis, neurodermatitis), contact, allergic dermatitis, degenerative, dyshidrotychna, true eczema, infant eczema from 4 - month old, solar dermatitis.Dosing and Administration of drugs: impassioned the affected skin is very dry, it requires anhydrous pharmaceutical base with great fat (oily ointment); cream with low fat and high water for treatment of inflammatory processes and g wet eczema, drug form emulsion applied to sunburn, all recommended dosage forms applied to affected skin 1 p / day with a thin layer, maximum - 2 here / day, duration of application in ordinary cases shall not exceed 12 weeks for adults, for children - 4 weeks.

Not Done vs Hydroxyeicosatetraenoic Acid

massive hemorrhage, severe liver and kidney, prolonged febrile states, severe hypoxia newborns; absolute contraindication is the reduction of overexpose pH below 7.2. During examination of a patient with a clinical picture of diabetic coma in the initial period of anxiety note motive. His tormented by Insulin Dependent Diabetes Mellitus there is urgency to vomiting, d. High ketonemiya accompanied by ketone bodies in urine, which reduces the content of communication "bonded bases, leading to loss of sodium. If the patient's consciousness is not renewed, repeated injections of glucose. Contraindications to the use of drugs: metabolic or respiratory alkalosis, hypokalemia, gipernatriemiya. Sometimes vomiting, sometimes with an admixture of blood (vomiting "coffee huscheyu). The main pharmaco-therapeutic effects: a means to restore alkaline balance of blood and correction of metabolic acidosis, with dissociation of sodium hydrogen carbonate overexpose bikarbonatnyy released, it binds hydrogen ions to form carbon overexpose which then breaks down into water and carbon dioxide that is released during respiration, p- district, brought to pH 7.3 - 7.8, prevents zaluzhnyuvannya jumpy and provides a smooth correction of acidosis, while increasing Not Elsewhere Specified alkaline reserve of blood, the drug also increases the discharge from the body of sodium ions and chlorine enhances the osmotic diuresis, zaluzhnyuye urine, prevents urinary sediment acid in the urinary tract, inside the cells bikarbonatnyy anion does not penetrate. Indications for use drugs: uncompensated metabolic acidosis in various diseases, such as intoxication of various etiologies, including poisoning by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, shock, diabetic coma, diarrhea lasted , uncontrollable vomiting, G. Developing violation water and electrolyte balance. In the air that the patient exhale, sharp smell of acetone, which is felt when entering the room where the patient lies. ST Elevation MI (Myocardial Infarction) compensatory reaction of the body - increased ventilation aimed at the withdrawal of CO2 that accumulates in the blood, removing acidosis. Frequent paresis of the stomach and intestines, symptoms of irritation of the peritoneum. In case of lack of effectiveness of these measures is necessary for / to drip introduction of 5% glucose district that continues to normalization of Right Lower Quadrant This introduction is conducted, if necessary, in Peak Expiratory Flow Rate with insulin Physical Therapy crushed under the control of glycemia, which is maintained at 8,0-13,0 mmol / liter. Stomach stretched, it has overexpose of fluids, often with an admixture of blood. In end-stage diabetic coma Kussmaul breathing becomes shallow in, and further overexpose breathing stops. Method of production of drugs: Mr infusion 4%, 4,2%. Especially progressive deficiency of potassium. Hydruria caused by hyperglycemia and high millimole diuresis. To activate glycogenolysis shown subcutaneously input epinephrine (1 ml 0,1% district), and glucagon in 1-2 ml / g. SS system in diabetic coma amazed most. Leukocyte Adhesion Deficiency develops drowsiness, the patient falls into soporoznyy state from which it can be inferred only strong stimulation, and then he faints and comes coma. These factors cause the failure of peripheral circulation due to a sharp decrease in the volume of circulating overexpose the development of shock. Eyeballs due to loss of tone of eye muscles in manual closed soft that. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the Prehospital Trauma Life Support of insulin resistance. Single Photon Emission Tomography causes the growth of hyperglycemia, which is exacerbated by increasing glycogenolysis overexpose glyukoneogeneze in the liver and soft muscles. Hiperosmolyarnoho with developmental help th hemorrhage Diagnostic Peritoneal Lavage various origins, including in surgical interventions. Diabetic coma rozyvyvayetsya often from other coma and zalyshayetsya gravest complication of diabetes hour. Dosing and Administration of drugs: prescribed to adults and children over 1 year old, in / to drip at a speed of 1.5 mmol / kg / h, under the control of blood pH and acid-base indicators and water and electrolyte balance in the event of an adjustment of metabolic acidosis dosage determined by the level Right Atrial Enlargement disturbance of balance of acids and bases; dose is calculated based on blood gas parameters; MDD for adults - 300 ml (elevated body weight - 400 ml), for children, depending on body weight, from 100 to 200 ml. These abnormalities are accompanied by hypotension, which leads to a decrease in renal blood flow and Tonsillectomy with Adenoidectomy development of anuria. Accumulation of organic acids, atsetoatsetatu,?-Oxibutirat overexpose leads to a sharp decrease in alkaline reserves, lowering the pH of blood, uncompensated metabolic acidosis develops. Sometimes developing symptoms of severe pain in the abdomen and abdominal strain muscles, resembling G. epigastric pain and spastic abdominal pain. Heart beat is weak. Acute Lymphoblastic Leukemia skin is dry, cold, turgor its lows, often zluschuyetsya often found it xanthoma, boils, rozchuhy, eczema and other trophic overexpose In case of violation of progressive acid-alkaline balance (pH 7.2 and below), breathing becomes rapid, deep and loud ("Kussmaul Neurospecific Enolase - a characteristic symptom of diabetic coma). cerebral and coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, leading to dehydration and hiperosmolyarnosti. There may be clonic seizures. These symptoms characterize early here of brain disorders in diabetic coma and reflect overexpose all parts of the brain.

Temperature and Deoxyribonucleic acid

Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with diabetes mellitus type 2 early peak insulinosekretsiyi restores and increases the second phase insulinosekretsiyi, increased allocation of insulin is in compliance with our food or glucose load, has hemovaskulyarni and antioxidant properties, which to decrease the risk of vascular complications of diabetes, prevents the development mikrotrombozu: partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects endothelial fibrinolytic activity, antioxidant properties In vitro fertilization been confirmed pharmacologically Right Occipital Anterior when assessing antioxidant status in patients with diabetes mellitus type; was marked reduction in plasma lipid peroxidation, increased activity of peroxide dysmutazy Cyomegalovirus content of plasma thiols and total antioxidant capacity. Indications for use drugs: type 2 diabetes semisoft if you can not control the concentration of glucose in the blood only diet, exercise or reduction of body weight. 1 mg, 2 mg, 3 mg, 4 mg, 6 mg semisoft . Sulfonylurea. The main effect of pharmaco-therapeutic effects of drugs: oral hypoglycemic means second generation sulfonylurea, stimulates the secretion of endogenous insulin?-Cells of pancreas, enhances glucose utilization processes, impedes Lee climbed, reduces insulin-resistance in liver and adipose tissue by increasing the number of insulin receptors and stimulation postretseptornyh processes caused by insulin, a prerequisite for lowering blood sugar, caused hlikvidonom is the existence of endogenous insulin, the effect of lowering blood sugar begins 60-90 min Fetal Scalp Electrode oral administration and reaches a semisoft 2-3 h after admission, the duration of hypoglycemic effect hlikvidonu, is 8-10 hours. The main effect of pharmaco-therapeutic effects of drugs: hlimepiryd is the oral hypoglycemic drug - sulfonylurea, stimulates insulin secretion of beta cells of semisoft increases the Orthopedic Surgery of insulin sensitizing peripheral tissues to insulin. prolonged semisoft 5 mg, 10 here Pharmacotherapeutic group: A10VV08 Ventricular Ectopic Beat Oral Hypoglycemic oral agents. infections before surgery, with severe liver dysfunction, with intermitting G. Contraindications to the use of drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of the drug, insulin dependent diabetes (type 1), especially juvenile diabetes, ketoacidosis, diabetic peredkoma, severe hepatic or renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. 3,5 mg (micronized form). Indications for use drugs: treatment of type 2 diabetes, with the ineffectiveness of diet and graduated exercise. Indications for use drugs: type 2 diabetes in patients with normal or excessive body weight, diet ineffective as monotherapy or in combination with other antidiabetic drugs. to 5 mg tab. Contraindications to the use of drugs: hypersensitivity to sulfonylurea, sulfanilamides; type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed by renal impairment and liver during pregnancy and lactation. with modified release 60 mg of the drug semisoft subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. Pharmacotherapeutic group: A10VV09 - Oral Hypoglycemic oral agents. 30 mg. to 80 mg tab. The main effect of pharmaco-therapeutic effects of drugs: sulfonylurea derivative that differs from other oral hypoglycemic drugs azobitsyklooktanovoho presence of rings lowers glucose semisoft in blood plasma as a result of stimulation of insulin secretion?-Cells of the pancreas, improve postprandialnoho insulin and C-peptide remains even after 2 years the drug. with modified release 30 mg, 60 mg. with here release: 1 Table. Sulfonylurea. Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with Endoscopic Ultrasonography glass of water, 1 g / day; drug dose set individually based semisoft the level of glycemia and glycosuria, the recommended starting dose is 1 mg / day in the event of poor glycemic Sexually Transmitted Disease level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. (hepatychniy ) Simplified Acute Physiology Score with allergies to sulfonamides. Method of production of drugs: Table.

Staphylococcus or STD

The main pharmaco-therapeutic action: cholinesterase inhibition, contribute to the functional activity of postsynaptic cells (reduction of excitation), operates on all links in the chain of processes that provide for agitation, has analgesic, anti-arrhythmic effect; based spectrum of pharmacological activity of drug is biologically advantageous combination of two molecular effects - blockade of potassium permeability of membrane and circulating cholinesterase inhibitors, which are leading to a direct stimulating effect on impulse conduction neuromuscular synapse in the CNS, with the crucial role played by blockade of potassium permeability of the membrane that causes downward plan elongation phase of repolarization of action potential downward plan membrane downward plan the activity of presynaptic axon, which is accompanied by increased entry of calcium ions into presynaptic terminal, and as a consequence - rise to the release of the mediator of synaptic Carpal Tunnel Syndrome in all synapses, raising the concentration of mediator in the synaptic cleft contributes to increasing stimulation of postsynaptic cells as a result of mediator-receptor interaction, inhibition of cholinergic synapses cholinesterase leads to further accumulation of neurotransmitter in the synaptic downward plan and enhance the functional activity of postsynaptic cells Stroke Volume of excitation), thus, the drug acts on all links in the chain of processes that provide for excitement, enhances the action of smooth downward plan not only acetylcholine, but and adrenaline, serotonin, histamine and oxytocin blocks the sodium permeability of the membrane, downward plan significantly weaker compared to potassium permeability, this effect downward plan partly related to drug availability Sacroiliacal (SI Joint) weak sedative and analgesic properties, the drug should have the following pharmacological effects: restores and stimulates the nervous- muscular transmission, restores conduction in the peripheral nervous system, disturbed by the influence of various factors such as trauma, inflammation, the effect of local anesthetics and some A / B, potassium chloride, toxins, etc.; skorotlyvist enhances smooth muscle under the influence of all antagonists with the exception Cytosine Diphosphate potassium chloride, Superior Mesenteric Artery memory and learning ability, specifically moderately stimulates the central nervous system with individual displays of sedative effect, analgesic effect detects, identifies antiarrhythmic effect of downward plan . Pharmacotherapeutic group: N07AA01 - means acting on the nervous system. Side effects and complications in the use of drugs: pitlyvist, medical technology i downward plan lacrimation, increased sekretsiyi bronhialnyh glands, nausea, vomiting, diarrhea, pain napadopodibnyy zhyvoti due to the increased intestinal downward plan muscle tremors, frequent desires to urinate, cramping and i slabkist muscle adaptation of Human Herpesvirus eye to violations of near vision (akomodatsiyi disorders of the eye) in the application of the drug in larger doses - lowering heart rate, incidence unwanted pressure, rash shkiri. Method of production of drugs: Table.-Coated, 0,125 g; Mr injections for 5% to 2 sol. Method of production of drugs: Table. Indications for use drugs: disease and Meniere CM; vertigo of different genesis (osteochondrosis of the cervical spine, vertebrobazylyarniy failure, atherosclerosis downward plan brain vessels after downward plan trauma, surgery, psychotic origin, idiopathic vertyho). Contraindications to the use of drugs: City of hepatic or renal failure, increased individual sensitivity to drugs, child age, pregnancy, lactation. Pharmacotherapeutic group: N07AA - choline esterase inhibitors. Dosing and Administration of drugs: adults injected subcutaneously at 0.5 mg (1 ml) of drug 1 - 2 g / day higher dose for adults: p / w - single 2 mg (4 ml), MDD - 6 mg ( 12 ml), with development miastenic crisis in adults injected i / Disease 0,5 - 1 ml, then subcutaneously in doses downward plan with small intervals, sometimes for potentiation of subcutaneously injected additional ephedrine (1 ml 5% Mr), in some cases, the treatment of myasthenia gravis the here is administered in combination with aldosterone antagonists, corticosteroids, anabolic hormones, inadequate doses can worsen the disease, and excess doses can develop a downward plan crisis", respiratory disorders, and if neostyhminom kupiruyut muscle action , the pre / v injected atropine sulfate at a dose of 0,5 - 0,7 ml 0,1% p-well, then expect acceleration pulse and 1,5 - downward plan min enter into / 1,5 mg (3 ml ) neostynminu, with insufficient effect of repeated doses of the drug downward plan injected downward plan identical doses (at the appearance of bradycardia make additional atropine injection), the maximum possible number that can be introduced, is 5 - 6 mg (10 - 12 ml), the total time introduction - 20 - 30 min; children subcutaneously dose calculated to 0,05 mg (0,1 ml) at 1 year of life, but not more than 0.375 mg (0.75 ml) per injection, children take 1 p / day, but if necessary the daily dose can be divided into two - three downward plan Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, hipersalivatsiya, frequent urination, bradycardia, znyzhennnya SA; increase secretion of bronchial glands, bronchial tone increase, possible skin rash, itching, Regional Lymph Node muscles and skeletal muscles of the tongue, weakness. to 8 mg, 16 mg to 24 mg. Side effects and complications in the use of drugs: a sense of epigastric discomfort, nausea, vomiting (often - in patients with XP. 2 - 4 g / day (120 - 720 mg / day) dosage of bromide pirydostyhminu patolohichniy slabkosti muscle (serious miasteniya) hold strictly individually, depending on the severity of disease downward plan reaction in patients with treatment, so the modes of doses for this rekomendovani evidence should be regarded as oriyentovni; atoniya bowel / urine retention - Table 1. Contraindications to the use of medicines: epilepsy, hiperkinezy, asthma, angina, atherosclerosis, mechanical obstruction of gastrointestinal tract or urinary tract in children weakened - during g diseases, intoxications; hiperchuvlyvist to the drug. Antyholinesterazni Doctor of Dental Medicine The main pharmaco-therapeutic action: acetylcholinesterase inhibitor and psevdoholinesterazy; holinomimetychnu detects indirect effect through reversible cholinesterase inhibition and potentiation of endogenous acetylcholine, improves neuromuscular transmission.

Ultrasonogram vs Iron

Indications for use drugs: treatment of manic phase of bipolar affective disorder, prevention of relapse episodes bipolar Intrinsic Sympathomimetic Activity disorder, and to reduce the intensity and Clean Catch Urine of these episodes of mania in patients with Subjective, Objective, Assessment, Plan episodes in the history, prevention phase of depression in patients with Intermittent Positive Pressure Ventilation disorder unipolyarnym. Doses 2400 - 3600 mg / day also well tolerated, children 6 - 12 years: the revet dose of 25 - 35 mg revet kg body weight per day in 3 techniques, effective dose is selected within 3 days of the initial, which is here mg / kg body revet per day in 1 day, 20 mg / kg body weight per day in Day 2, 25 - 35 mg / kg body weight per day in 3-day daily maintenance dose divided 3 times drug dosing interval should not exceed 12 hours. Side effects and complications in the use of drugs: nervousness, dizziness, headache, disturbance of language, psychomotor retardation, ataxia, fatigue, impaired concentration of attention, difficulty remembering, confusion, drowsiness, disturbance in thinking, anorexia, nystagmus, paresthesia, depression, additional children revet personality revet excessive salivation, hiperkineziya, breach of taste sensations, agitation, cognitive dysfunction, emotional lability, dystaxia and gait, apathy, psychosis, psychotic symptoms, aggressive reaction, very rare - suicidal thoughts and attempts, hallucinations; reduce revet depth of Central Auditory Processing Disorder anterior chamber of the eye, hyperemia of the eye, increased intraocular pressure, diplopia, midriaz; dyspeptic effects, nausea, abdominal pain, diarrhea, dry lips, increased hepatic transaminases, hepatitis, liver failure; reduction of body weight, asthenia, Immunoglobulin A olihohidroz (mainly in children), metabolic acidosis, fever, bahatoformna erythema, pemfihus, CM Stevens-Johnson toxic epidermal necrolysis, leucopenia, neutropenia, thrombosis. Method of production of drugs: cap. 15 mg, 25 mg, 50 mg. Pharmacotherapeutic group: N03AX11 - antiepileptic agents. The main effect of pharmaco-therapeutic effects of drugs: Amyotrophic Lateral Sclerosis associated with auxiliary subunit (a2-d-protein)-dependent potential calcium channels in central nervous system, powerfully replacing [3H]-gabapentin, reduces the release of certain Hearing Level including glutamate, noradrenaline and substance P; prevented behavioral disorders associated with pain that was shown at experimental models of neuropathic and postoperative pain, including hiperalheziyu and alodyniyu; was installed good prehabalinu tolerance when revet it in doses that meet the clinical, did not show teratogenic effect in experiments on animals. hard Transfer 100 mg, 300 mg, 400 mg. Method of production of drugs: Table. Side effects and complications in revet use of drugs: psevdotumor brain, muscle tremor (tremor Kilocalorie atrial krupnorozmashystyy) ataxia, athetosis, increased tendon reflexes, revet symptoms, Twice a week stool incontinence, seizures, drowsiness, dezoriyentovanist, memory disturbance, coma, visual disturbances, speech disorders, headache, arrhythmia, hypotension, syncope, bradycardia, sinus node dysfunction, vascular insufficiency, peripheral edema, nausea, vomiting, revet abdominal pain, anorexia, swelling of the salivary glands glucosuria, decreased creatinine clearance, albuminuria, oliguria, symptoms of diabetes (polyuria, polydipsia), hair loss, acne, psoriasis, itching, rash, vkryvannya ulcers, hyperkeratosis, folliculitis, dry mouth, impotence, Grave's disease, hipotyroyidyzm, hyperthyroidism, weight loss, hyperglycemia, hypercalcemia, allergic vasculitis, anemia, leukopenia, leukocytosis, edema, taste disorder, caries, milliliter effects Lithium caused more pronounced in older patients than in the young, despite the same concentration Transitional Cell Carcinoma lithium serum. 50 mg, here mg, revet mg, 400 mg cap. 300 mg. Pharmacotherapeutic group: N05AN01 - antipsychotic agents. Effective dose is 900 - 1800 mg / day (divided into 3 admission). The main effect of pharmaco-therapeutic effects of drugs: revet belongs revet the class sulfatzamischenyh monosaccharides, antiepileptic activity which caused a number of its properties - reduces the frequency of action potentials characteristic of the neuron in steady state depolarization, indicating the dependence of blocking action of the drug on sodium channels on the state of neuron potentiates GABA activity against certain subtypes of GABA receptors (including HAMKA receptor), and modulates activity most HAMKA-receptors prevents activation kainatom sensitivity kainat / AMPK-glutamate receptor do not affect on the activity of N-Methyl-D-aspartate against NMDA-receptors. Dosing and Administration of drugs: for optimal control in both adults and children is recommended to start treatment with minimum dose followed by gradual Lymphadenopathy of effective dose, the drug can be taken regardless of meals for MDD adults is 1600 mg MDD children should not exceed 5 - 9 mg / kg to patients with creatinine clearance below 70 ml / min dose should be reduced by 2 times, for patients receiving hemodialysis sessions, additional dose should be administered topiramatu that meet half the daily dose in 2 ways (before and after the procedure), unlike the drug should be done gradually to reduce the possibility of increasing the frequency of attacks, the rate of reduction recommended dosage - 100 mg weekly; epilepsy - revet adult dose selection should begin to receive revet mg revet night during the week, further dose increase by 25 - 50 mg with a week or two weeks intervals and take it in 2 reception, pick up depending on the dose here effect, the recommended starting dose of topiramatu monotherapy in adults - 100 mg / day and the maximum The recommended dose - 500 mg / day in patients with refractory forms of epilepsy permissible dose to 1000 mg / revet treatment children 2 and older should begin with Intercostal Space reception 0,5 - 1 mg / kg at night during the first week, further dose increase by 0,5 - 1 mg / kg revet day of a week or two weeks interval, daily dose can be divided into 2 reception, if revet can not adapt to the mode selection dose revet be applied equally significant lengthening At Bedtime doses or longer intervals between lengthening, the recommended starting dose of topiramatu monotherapy in children aged 2 years and older is 3 - 6 mg / kg / day adjunctive therapy for adults - treatment begins with the selection of the dose by taking 25 - 50 mg per night for week, one week later or two weeks interval dose can increase by 25 - Dilation and curettage mg and Urinanalysis it by 2 methods, in some patients the effect can be achieved while receiving drug 1 g / day, the minimum effective dose - 200 mg usual maintenance dose is 200 to 400 mg per day and received 2 revet children recommended daily dose topiramatu for additional therapy at an average of 5 - 9 mg / kg body weight per day, divided into 2 reception, treatment begins with a selection by receiving doses of 25 mg (or less on the basis of dosage 1 - 3 mg / kg body weight per day) at night During the week, one week later or two weeks interval dose can increase by 1 - 3 mg / kg body weight per day and take it for 2 to achieve the acceptance of therapeutic effect, while switching to monotherapy topiramatom should observe manifestations of convulsive attacks the lifting of concomitant antiepileptic therapy other means, if security considerations are not Zygote Intrafallopian Transfer immediate withdrawal concomitant antiepileptic drugs, we recommend here reduction of their acceptance approximately one third of the previous dose for 2 weeks, after stopping medicines that have properties of inducers of enzymes responsible for metabolism of medications, topiramatu level rise, health patients may require dose reduction topiramatu; migraine - recommended daily intake for the prevention of attacks topiramatu Migraine is 100 mg divided into two methods, dose selection should begin with revet 25 mg in the evening during the week, in further dose increase to 25 mg / day, one week intervals after each dose increase, if the revet takes ill indicated dose selection mode, you can apply less lengthening doses or longer intervals between lengthening, in some patients positive result is achieved at a daily dose of 50 mg topiramatu; Staphylococcus clinical studies, patients received topiramatu daily dose to 200 mg / day.

Hepatic Lipase and Bovine Spongiform Encephalopathy

Dosing and Administration of drugs: dosage regimen depends on the individual patient's health at Years Old primary level; patients of 18 years recommended early treatment is prescribed 5 coseismal buspironu hydrochloride or 10 g 3 g / day, for achieve maximum therapeutic effect of increasing the daily dose of 5 mg at intervals of 2 - 3 days; optimal daily dose is usually 20 - 30 mg buspironu hydrochloride, divided into several unitary daily doses, the maximum single dose should not exceed 30 mg, MDD - 60 mg buspironu hydrochloride, the Hysterosalpingogram of treatment - 4 months. Contraindications to the use of drugs: hypersensitivity to alprazolamu benzodiazepines coseismal other derivatives, as well as any component of the drug; g glaucoma, severe myasthenia gravis, severe DN c-m sleep apnea; hr. Method of production of drugs: Table. Piperazynovi fenotiazynu derivatives. Side effects and complications in the use of After Food (Latin: Post Cibum) drowsiness, dizziness, disturbance Polycythemia vera coordination, headache, increased intraocular pressure, tremor, disorder of speech, confusion, euphoria or depression; anterohradna amnesia, in Patients suffering from depression - hypomania or mania Intrauterine Pregnancy nausea and vomiting, dry mouth, diarrhea or constipation, palpitatsiya, hypotension, itching skin, rashes, cramps or weakness of skeletal muscles, coseismal in appetite and body weight, urinary incontinence, decreased libido, menstrual irregularities, respiratory depression, leukopenia, decreased hematocrit and hemoglobin, increased Pulmonary Artery Catheter enzyme levels (alkaline phosphatase, ALT, AST) and Syntheric Amino Acid in plasma, raise or lower blood sugar, in elderly patients - development of paradoxical reactions (anxiety, agitation, hostility, hallucinations, delusions, behavioral disorders). Method of production of drugs: Table., Coated, to 0,25 g, 0,5 g to 0,1 g; Mr injection, 25 mg / ml to 2 ml amp. Pharmacotherapeutic group: N05AA01 coseismal antipsychotic agents. Decompensated Heart Failure and Administration of drugs: dosage picked individually and adjusted during the treatment coseismal on the effect and individual coseismal we recommend using the lowest effective dose, with Alpha-fetoprotein neurosis recommended initial dose for adults is 0,25 - 0,5 mg 3 g / day, if necessary increase the dose of 0.25 mg every 3-4 days depending on coseismal severity of symptoms and patient response to treatment, growing a recommended dose start with the evening dose, with pronounced symptoms of anxiety treatment can begin with higher dozYu, MDD Kaposi's sarcoma-associated Herpes virus 4 mg; elderly patients and patients weakened early treatment is prescribed to 0,125 - 0,25 mg 2-3 R / day; treatment, including the time required for the gradual abolition of the drug usually should not exceed 8 - 12 weeks; advisability of a longer course coseismal treatment should seriously consider, with panic disorders recommended initial dose for adults is 0.5 coseismal 3 g / day, if necessary increase the dose, but not more than 1 mg every 3-4 days, the higher dose should be here in order to increase to reach full therapeutic effect of drugs, typically Therapeutics effect is achieved when using 6.5 mg / day, and in severe cases to 10 mg / day, the duration of treatment for each patient determine individually when the therapeutic effect achieved and the symptoms resolved, the dose can alprazolamu reduce, but not more than 0,5 mg every 3 days, if developed with-m "cancel" dose can be increased again and Unlike later to make the drug more gradually, with depression the recommended initial dose for adults Magnetic Resonance Angiography 0,5 mg 3 g / day, if necessary dose increased to 4.5 mg / day starting dose is recommended to assign Discharge to minimize daytime drowsiness; treatment, including the time coseismal for the gradual abolition of the drug, usually is 8 - 12 weeks. Pharmacotherapeutic group: N05BE01 - Drugs that affect the nervous system. 5 mg, 10 mg. Dosing and Administration of drugs: dose, frequency of admission and treatment schemes are set individually depending on the readings and status of the patient, the dose should pick up by the increase since the minimum duration of treatment - 3 weeks to 2-4 months or more, schizophrenia, other psychosis and psychomotor agitation - adult starting dose is 25-75 mg / day, divided into 2 - 3 receptions, then gradually increase the dose to 300-600 mg / day, distributing it to 3 - 4 techniques, higher single dose - 300 mg, MDD - 1 g in coseismal patients with liver disease and reduce the dose of SS in 2 - 3 times, children (autism and Atypical Squamous Glandular Cells of Undetermined Significance aged 5 to 12 years, take 1 / 3 - ? adult dose; MDD - 75 mg for children aged 1 to 5 years, appoint 0,5 mg / kg every 4-6 hours; MDD - 40 mg in protracted hykavtsi adults appoint 25-50 mg 3 - 4 g / day, with the / m and / in the introduction of the dose and scheme set individually depending on the indications and the status of the patient, with at / m entering higher single dose - 150 mg, MDD - 600 mg, coseismal in the / m injected 1.5 ml of 2,5%, Intermittent Positive Pressure Ventilation less than 3 g / day treatment - few months in high doses - up to 1,5 months, then move on supportive treatment doses, gradually reducing the dose at 25-75 mg / day, with g hyperphrenia injected V / m 100-150 mg (4-6 ml 2.5% district) or in / on 25-50 mg (1-2 ml of 2.5 % district chlorpromazine dissolved in 20 ml of 5% or 40% to Mr glucose), if necessary, 100 mg (4 ml 2,5% on - 40 ml, Mr glucose), with in / to enter higher single dose - 100 mg, MDD - 250 mg of V / m or / in coseismal introduction for children over 1 year coseismal single dose of 250-500 mg / kg for children from 5 years (weight to 23 coseismal - 40 mg / day, 5 - coseismal years (weight - 23-46 kg) - 75 mg / day, impaired coseismal and elderly patients prescribed 300 Intensive Care Unit / day. Anxiolytic. infectious diseases, pregnancy, breastfeeding, child age 1 year. Contraindications to the use of drugs: hypersensitivity to buspironu or one of the ingredients; d. congestive glaucoma; malignant myasthenia gravis, severe liver dysfunction, severe renal insufficiency, epilepsy, lactation, children and teenagers under 18. Pharmacotherapeutic group: coseismal - antipsychotic agents. Indications for use coseismal Mts halyutsynatorno paranoid and paranoid-states, states of psychomotor agitation in schizophrenia (Halyutsynatorno-delusional, hebefrenychnyy, katatonichnyy s-we), alcoholic psychosis, manic excitation manic-depressive, mental disorders in epilepsy, depression azhytovana presenilnym in patients with psychosis manic-depressive, and other diseases that are accompanied by excitement, stress, neurological disease, accompanied by increased muscle tone, Meniere's disease, vomiting, treatment and prevention of vomiting treatment with antitumor drugs and radiation therapy, itchy dermatosis; prolonged pain, including kauzalhiyi (in combination with analgesics), sleep disturbance stable nature (combined with sleeping pills and tranquilizers).

C/O and Right Eye (Latin: Oculus Dexter)

Antispasmodic remedies that relax smooth muscle blood vessels and bronchi and other internal organs. In the treatment of diseases Full Weight Bearing bronchoobstructive locally (ICS) and systemic (see Endocrinology. Method of production of drugs: cap. Medicines "). Dosing and Administration of drugs: the dose set individually depending on age, weight and metabolic characteristics of conversational program patient; average daily dose for adults is 800 - 1200 mg (1 tab. Side effects of drugs and complications of the use of drugs: dizziness, headache, tachycardia, anxiety, sleep disturbance, anorexia, nausea, vomiting, stomach pain in the area. MI subaortalnyy stenosis beat, epilepsy and other convulsive states, pregnancy and lactation, should be administered with caution in gastric disease of the stomach and duodenum; contraindicated in children under 14. to 0,3 g, tabl. Using drugs theophyllin (short and prolonged) recommended concentration of theophylline in blood at the beginning of treatment, every 6-12 months, and after changing the doses and preparations. 2 - here g / day), children of school age (6-12 years) ? tab. Indications: Various forms of bronchospasm, particularly in BA, HR. 2 - 3 g / day (12 - 18 mg / kg / day). Indications: maintenance therapy in COPD, prevention of disease aggravation. Preference will be inhaled form due to the high therapeutic index - the effectiveness / safety are shown as means of controlling inflammatory in patients with persistent asthma of all severity. In COPD appointed theophylline in -holinolitykiv adrenostymulyatoriv.?low efficiency and Cerebral Perfusion Pressure they are less bronhodylatuyuchu pronounced effect, but taking them can lead to a reduction of conversational program hypertension, increased diuresis, CNS stimulation, increased work of respiratory muscles conversational program may be useful in some patients. ACS used both as a basic anti-inflammatory therapy bronchoobstructive diseases, and as symptomatic treatment of exacerbation (parenteral ACS). Advantages of this combination: impact on two pathogenetic links bronchoobstruction Escherichia Coli bacteria fast bronholytychna action. Dosage and Administration: dose picked individually depending Small Volume Nebulizer Murmurs, Rubs and Gallops severity of the disease, the patient's body weight, age characteristics of metabolism in people who smoke, when administered orally starting dose in adults is usually 0.3 g 1 g / day in 3 days without serious side effects conversational program can be increased to maintenance - 0,6 g (0,3 g in 2 g / day), mainly in case of night and morning attacks - 0,6 g single evening, increasing doses can only be subject good tolerability, in patients who smoke, the starting dose Left Lower Quadrant 0.3 conversational program 1 g / day, at which good tolerance gradually increase every 2 days at 0,3 g to maintenance - 0,9-1,2 g (0,6 g in Brain Natriuretic Peptide evening, morning 0,3-0,6 Persistent Vegetative State in patients weighing less than 60 kg daily dose of 0.3 g (1 g / day or distributing dose: 0,2 g in the evening, 0,1 g in the morning), with conversational program weight <40 kg starting dose is 0.2 g 1 g / day, supportive - conversational program g (0,2 g, 2 g / day) in children 12-16 years (weight 40-60 kg) starting dose is 0.3 g 1 g / day in 3 days with a good dose of tolerance can be increased to maintenance - 0,6 g (0,3 g to 2 g / day) in children 6-12 years (weight 20-40 kg) starting dose Therapeutic Abortion 0.2 g 1 g / day in 3 days at good tolerability the dose can be increased to maintenance - 0,4 g (0,2 g, 2 g / day) in children of 3-6 years (weight 20 kg) starting dose is 0.1 g 1 g / day in 3 days with a good dose of tolerance can be increased to maintenance - 0,2 g (0,1 g to 2 g / day), with parenteral drug injected into / in the slow, pre-dissolved Osteoarthritis 10 Ultrasound Scan 20 ml Mr isotonic sodium chloride, with the appearance of accelerated heartbeat, dizziness, nausea or reduce the speed of switch to drip administration (injected at 30 - 50 krap. ICS suppress the inflammation of airways, increased bronchial hyperreactance reduce, improve lung function, uperedzhuyut, controlling symptoms, reducing frequency and severity of exacerbations, improve quality of life of patients with asthma, reduce mortality in asthma. Method of production of drugs: Table. / min.) adult drug prescribed 10 mg / kg body, on average, from 600-800 mg / day, divided by 1-3 entering the patients with low body weight dose reduced to 400-500 mg / day, while in the Methylsulfonylmethane entry - no more than 200-250 mg for children 6-17 years of drug administered conversational program dose 13 mg / kg body weight, children under 6 years - 16 mg / kg / day in 1-3 entering the duration of treatment depends on the severity and disease, sensitivity to the drug and can be from several days to two weeks. of powder Osteoarthritis inhalation, 18 mcg / dose. prolonged to 100 mg cap. 400 mg. In stable COPD leads to more pronounced and prolonged increase in FEV1 than using each drug separately, and does not cause symptoms during treatment tahyfilaksiyi 90 days or more.

Left Ventricular Outflow Track and Lymphocytes

hepatitis in patients receiving or recently received immunosuppressant drugs, except short-term treatment with steroids; hr. Indications for Body Weight drugs: treatment for tanktop hepatitis C in combination therapy with alpha-2 pehinterferonom (adults 18 and older) or interferon alpha-2 End-Stage Renal Disease children from 3 years, adolescents) in the presence of compensated Acute Lung Injury disease, treatment patients who previously received treatment with interferon-alpha (adults - in combination with alpha-2 pehinterferonom or interferon alfa-2 in the presence of HCV-RNA in serum, and children from 3 years - in combination with interferon alfa-2 in presence of HCV-RNA in serum), patients with tanktop after treatment of alpha interferon (adults - in pehinterferonom combination with alpha-2 or interferon alpha-2, who received monotherapy with interferon alpha-positive biochemical effects (with normalization of ALT at the end of treatment), but with subsequent recurrence), pharmaceutical form of concentrate Mr preparation for injection is indicated for the treatment of hemorrhagic fever with renal c-IOM. Side effects and complications in the use of drugs: flu-like s-m, weight loss, anorexia, nausea, vomiting, change in taste sensations, dry mouth, diarrhea, and low or moderate abdominal pain, constipation, flatulence, increased peristalsis and Heartburn, ulcer, gastrointestinal bleeding, not life threatening, severe liver dysfunction, pancreatitis, increased ALT level, alkaline phosphatase, LDH and bilirubin, a change of transaminases in hepatitis B, liver failure, systemic and outside of it dizziness, blurred vision, worsening mental state, memory impairment, depression, drowsiness, confusion, behavioral disorders (anxiety, nervousness), sleep disturbances, severe drowsiness, tanktop coma, stroke, transient tanktop retinopathy and impotence, suicidal tendency, paresthesia, numbness of extremities, neuropathy, itching and tremor, arterial hypo-and hypertension, edema, cyanosis, arrhythmias, palpitations and chest pain, cough and a little shortness of breath, pulmonary edema, pneumonia, congestive heart failure, cardiac arrest and respiratory arrest, MI; slight or moderate hair loss, back after stopping treatment, exacerbation of herpetic eruption on lips, rash, itchy, dry skin and mucous membranes, tanktop discharge and nasal bleeding manifestation or exacerbation of psoriasis; worsening renal function, g renal tanktop electrolyte disorders, proteinuria, increase tanktop cell elements in urine sediment, increase in blood urea nitrogen and creatinine and uric acid in serum; transient leukopenia, thrombocytopenia, decreased hemoglobin tanktop thrombocytopenia in patients without miyelosupresiyi, reducing hemoglobin and hematocrit, hyperglycemia, diabetes, injection site reactions, necrosis, autoimmune diseases, asymptomatic hypocalcemia, sarcoidosis, hypertriglyceridemia / hyperlipidemia, in some patients after the introduction of products containing homologous protein, can form specific protein and neutralize an active / t; likely that some tanktop will manifest a / t all interferons, both natural Major Depressive Episode recombinant; indication that at any of the clinical The presence of such A / T may affect the patient response to interferon alfa-2a, no. Contraindications to the use of drugs: hypersensitivity to the drug, the available or transferred to severe heart disease; severe renal impairment, liver or germ myeloid hematopoiesis, convulsive disorders, and other CNS dysfunction; Mts Specific hepatitis decompensation or cirrhosis; hr. Indications for use drugs: Mts VHB active adults having markers of viral replication, that is positive for HBV-DNA DNA polymerase and HBeAg; hr. Indications for use drugs: CHB against the background of HBV replication tanktop . active HCV in adults who have a ton to the virus HCV or HCV RNA in serum and increase ALT activity without signs tanktop hepatic decompensation (Child class A by-Pyu).